PATENT CLAIM ANALYSIS

Application Number: 15781693
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2018-12
Patent Classification: ["424", "489000"]

Abstract:
The present invention relates to pharmaceutical compositions containing 2-((3-(4-cyanonaphthalen-1-yl)pyridine-4-yl)thio)-2-methylpropanoic acid or a pharmaceutically acceptable salt (hereinafter referred to as the “Agent”), more particularly to orally deliverable compositions containing the Agent; to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Claim (Index 5):
A modified release pharmaceutical composition according to  claim 2  or  3 , wherein the ratio of C max /AUC 0-24  is between 0.04 and 0.2.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.52273
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13160572', '15010212', '14255529', '14230053', '14589839']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7521658655103826
- 35 USC 102 Novelty (BERT): 0.5290670683610784
- Combined Prediction Score: 0.7298559857954522
- Mean Citation Score: 305.358114
- Max Citation Score: 343.80948
- Similarity Product: 226.4244711820936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test